If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLowland Inv. Regulatory News (LWI)

Share Price Information for Lowland Inv. (LWI)

Share Price is delayed by 15 minutes
Get Live Data
175.00    2.00 (1.16%)
Bid:
173.50
Ask:
175.00
Spread: 1.50 (0.865%)
Market Cap: £384.09m
LWI Live PriceLast checked at - London Stock Exchange

Intraday Lowland Inv. Share Chart

Edison issues update on Lowland IC

15 Aug 2023 07:15

RNS Number : 2690J
Lowland Investment Co PLC
15 August 2023
 

London, UK, 15 August 2023

 

Edison issues update on Lowland Investment Company (LWI)

Lowland Investment Company (LWI) targets above-average total returns, from a combination of capital and income, with a multi-cap investment policy that differentiates it from most peers in the UK Equity Income sector. Within its broad range of investment opportunities, selected large caps provide more immediate income, often with defensive characteristics, while small and mid-caps offer faster growth in income and dividends over time. LWI has a long track record of progressive dividends, which have grown c 7% pa over 10 years, and currently offers an attractive 5.2% yield. While investor focus on large-cap stocks, often with global businesses, has created a headwind for LWI's multi-cap approach and five-year NAV total return, the managers anticipate a broadening of market performance.

 

As they have observed in previous cycles, the managers expect market leadership to broaden as confidence grows. They believe that the market de-rating of SME companies is already discounting a severe recession, and often ignores robust performances and strong prospects. Stubborn inflation is yet to signal the peak in interest rates, making the timing of an SME recovery difficult to predict, but low valuations should mitigate further weakness and may attract further takeover activity. The potential for an SME recovery makes LWI an interesting complement to more mainstream trusts and a narrowing of the 10% discount to NAV would enhance shareholder returns.

 

Click here to view the full report.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first company in-market 17 years ago, Edison has more than 100 employees and covers every economic sector. Headquartered in London, Edison also has offices in New York, Sydney and Wellington.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Martyn King +44 (0)798 6268 072 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on: 

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAPIMITMTJBBFJ
Date   Source Headline
10th Jan 20251:33 pmRNSNet Asset Value(s)
9th Jan 20255:59 pmRNSTransaction in Own Shares
9th Jan 202512:13 pmRNSNet Asset Value(s)
8th Jan 20255:36 pmRNSTransaction in Own Shares
8th Jan 20251:25 pmRNSNet Asset Value(s)
7th Jan 20255:33 pmRNSTransaction in Own Shares
7th Jan 20252:26 pmRNSNet Asset Value(s)
6th Jan 20256:19 pmRNSTransaction in Own Shares
6th Jan 20253:06 pmRNSNet Asset Value(s)
3rd Jan 20255:56 pmRNSTransaction in Own Shares
3rd Jan 20252:26 pmRNSNet Asset Value(s)
2nd Jan 20256:05 pmRNSTransaction in Own Shares
2nd Jan 20252:21 pmRNSNet Asset Value(s)
31st Dec 202412:48 pmRNSNet Asset Value(s)
30th Dec 20242:06 pmRNSNet Asset Value(s)
27th Dec 202412:28 pmRNSNet Asset Value(s)
24th Dec 202412:37 pmRNSNet Asset Value(s)
23rd Dec 20243:49 pmRNSNet Asset Value(s)
20th Dec 20244:08 pmRNSMonthly Factsheet as at 30 November 2024
20th Dec 202411:56 amRNSNet Asset Value(s)
19th Dec 202412:58 pmRNSNet Asset Value(s)
18th Dec 202411:29 amRNSNet Asset Value(s)
17th Dec 20244:18 pmRNSHolding(s) in Company
17th Dec 20242:32 pmRNSNet Asset Value(s)
17th Dec 20242:22 pmRNSAnnual Report and Financial Statements Posting
16th Dec 20244:38 pmRNSHolding(s) in Company
16th Dec 20243:38 pmRNSNet Asset Value(s)
13th Dec 20242:17 pmRNSNet Asset Value(s)
12th Dec 202411:39 amRNSNet Asset Value(s)
11th Dec 202411:30 amRNSNet Asset Value(s)
10th Dec 202412:26 pmRNSNet Asset Value(s)
9th Dec 20243:56 pmRNSNet Asset Value(s)
6th Dec 20241:27 pmRNSNet Asset Value(s)
6th Dec 202412:19 pmRNSAnnual Financial Report
5th Dec 202412:48 pmRNSNet Asset Value(s)
5th Dec 20247:00 amRNSAnnual Financial Report
4th Dec 202411:58 amRNSNet Asset Value(s)
3rd Dec 202411:44 amRNSNet Asset Value(s)
2nd Dec 20243:18 pmRNSNet Asset Value(s)
29th Nov 20241:15 pmRNSNet Asset Value(s)
28th Nov 202411:27 amRNSNet Asset Value(s)
27th Nov 202412:21 pmRNSNet Asset Value(s)
26th Nov 20241:35 pmRNSNet Asset Value(s)
25th Nov 20243:39 pmRNSNet Asset Value(s)
22nd Nov 20242:01 pmRNSMonthly Factsheet as at 31 October 2024
22nd Nov 202412:40 pmRNSNet Asset Value(s)
21st Nov 202412:29 pmRNSNet Asset Value(s)
20th Nov 202412:11 pmRNSNet Asset Value(s)
19th Nov 202411:38 amRNSNet Asset Value(s)
18th Nov 20244:33 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.